COMMUNIQUÉS West-GlobeNewswire

ACTG Evaluates Osteoporosis Treatment as Novel Approach Targeting the HIV Reservoir
19/08/2026
Second Study in ACTG’s Small Clinical Trials Advancing HIV Remission and Cure Program CHAPEL HILL, N.C., Aug. 19, 2026 (GLOBE NEWSWIRE) -- ACTG, a global clinical trials network focused on HIV and other infectious [...]
Roji Health Intelligence Releases New Guide as CMS Expands the Role of Accountable Care Organizations
19/08/2026
As CMS expands specialty payment models and financial accountability, healthcare organizations must rethink how ACOs coordinate care, manage risk, and improve outcomes. CHICAGO, Aug. 19, 2026 (GLOBE NEWSWIRE) -- Roji [...]
Fortitude Invests $1.0 Million in HeartSciences at a 22% Premium with No Adjustment to the Merger Consideration
19/08/2026
Shares issued at $2.43, a 22% premium to the closing price on the purchase date, with Fortitude receiving no additional merger consideration in respect of the investment Fortitude purchased approximately $1,000,000 of [...]
Imprivata Recognized in Constellation ShortList™ for Healthcare IT Security
19/08/2026
Recognition highlights Imprivata's leadership in helping healthcare delivery organizations strengthen security while delivering fast, frictionless access to devices, applications, and other critical systems WALTHAM, [...]
Femasys Announces FDA Approval of Modular PMA Submission Approach for FemBloc®
19/08/2026
-- Modular PMA pathway advances FemBloc toward potential U.S. approval while Femasys builds commercial infrastructure across its reproductive health portfolio -- ATLANTA, Aug. 19, 2026 (GLOBE NEWSWIRE) -- Femasys Inc. ( [...]
InterCure Ltd. Announces 1-for-5 Reverse Share Split
19/08/2026
Strategic Action Aimed at Regaining Compliance with Nasdaq’s Minimum Bid Price Requirement and Protecting Continued Listing Status NEW YORK and HERTZLIYA, ISRAEL, Aug. 19, 2026 (GLOBE NEWSWIRE) -- InterCure Ltd. (the “ [...]
Regional Health Properties Reports Second Quarter 2026 Results
19/08/2026
.Reported Second Quarter Revenue of $24.4 million Generated Adjusted EBITDA from Operations of $0.7 million Continued Execution of Integrated Healthcare Platform Strategy ATLANTA, GA, Aug. 19, 2026 (GLOBE NEWSWIRE) -- [...]
Rakovina Therapeutics Announces Results from 2026 Annual General Meeting
19/08/2026
VANCOUVER, British Columbia, Aug. 19, 2026 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V: RKV) (FSE: 7JO0), a biopharmaceutical company advancing innovative cancer therapies through AI-powered drug discovery, is [...]
Infex Therapeutics to present new RESP-X Phase IIa data in late-breaking session at ERS Congress 2026
19/08/2026
Infex Therapeutics to present new RESP-X Phase IIa data in late-breaking session at ERS Congress 2026 Presentation will provide additional analysis from the Phase IIa study of RESP-X in Pseudomonas aeruginosa -colonised [...]
Novartis data at ESC Congress 2026 reinforce cardiovascular leadership and showcase progress in next-generation therapies
19/08/2026
Late-breaking Phase IV VICTORION-CHALLENGE data will evaluate Leqvio ® (inclisiran) vs. bempedoic acid in achieving LDL-C goals New AZALEA-TIMI 71 analyses will further characterize the bleeding profile of abelacimab in [...]
Psyence BioMed Welcomes U.S. Administration’s Latest Action to Accelerate Ibogaine Development
18/08/2026
Company says growing federal commitment to ibogaine aligns directly with the pharmaceutical development and manufacturing platform Psyence BioMed has built NEW YORK, Aug. 18, 2026 (GLOBE NEWSWIRE) -- Psyence BioMed Ltd [...]
Immunocine Cancer Center Expands as Demand Grows for Personalized Dendritic Cell Therapy
18/08/2026
HOUSTON, Aug. 18, 2026 (GLOBE NEWSWIRE) -- Responding to a growing number of patients seeking personalized cancer immunotherapy, Immunocine Cancer Center has opened a second treatment location in Cabo San Lucas, Mexico [...]
Flyte Partners with FullPAC to Bring Regional Aviation to the $11.4 Billion U.S. Political Campaign Market
18/08/2026
Strategic Partnership Positions Flyte as the Premier Regional Aviation Solution for Statewide Campaigns While Expanding Access to More Than 5,000 Candidates, SuperPACs and Political Organizations FullPAC (NASDAQ [...]
Zenas BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
18/08/2026
WALTHAM, Mass., Aug. 18, 2026 (GLOBE NEWSWIRE) -- Zenas BioPharma, Inc. (“Zenas” or the “Company”) (Nasdaq: ZBIO), a clinical-stage global biopharmaceutical company committed to being a leader in the development and [...]
Silo Pharma Receives Notice of Allowance for Canadian Patent Application for Novel PTSD Treatment
18/08/2026
Follows recent European patent grant and coverage in multiple international markets as Silo continues to strengthen licensed IP portfolio for lead therapeutic program SARASOTA, FLA., Aug. 18, 2026 (GLOBE NEWSWIRE) -- [...]
Eikon Therapeutics to Participate in KOL Event on Therapeutic Use of PARP Inhibitors in Oncology Hosted by Cantor Fitzgerald
18/08/2026
Event and Webcast to be held August 20th, 2026, 9:00 AM ET MILLBRAE, Calif., Aug. 18, 2026 (GLOBE NEWSWIRE) -- Eikon Therapeutics, Inc. (Nasdaq: EIKN) (“Eikon”), a late-stage clinical biopharmaceutical company dedicated [...]
Iridex Reports Second Quarter 2026 Financial Results
18/08/2026
MOUNTAIN VIEW, Calif., Aug. 18, 2026 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems, delivery devices, and accessories for the [...]
Acquisition of Own Shares
18/08/2026
Mechelen, Belgium; 18 August 2026, 22.01 CET; regulated information Within the framework of the repurchase program announced on June 9, 2026, Lakefront Biotherapeutics NV (Euronext & NASDAQ: LKFT) ("Lakefront") [...]
Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
18/08/2026
FOSTER CITY, Calif., Aug. 18, 2026 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq: GERN), a commercial stage biopharmaceutical company, today reported that, effective August 17, 2026, it granted stock options to purchase [...]

Pages